Description
Seeking men and women whose non-squamous non small cell lung cancer (NSCLC) has progressed after chemotherapy for a study of an investigational drug alone or in combination with an immune drug compared to the usual chemotherapy treatment.
Overview
Participants in this study will be randomly chosen to receive the investigational drug, the investigational drug in combination with an immune drug, or the standard chemotherapy.
What we're hoping for
We are studying whether the investigational drug alone or in combination is effective in reducing the risk of non-squamous non small cell lung cancer (NSCLC) from progressing or spreading.
Additional Information
ClinicalTrials.gov Identifier: NCT04310007